DLK1 and schizophrenia: We later observed changes in the expression of DLK1-DIO3 miRNAs in the left hemisphere of the entorhinal cortex (EC), an important brain region for high-level cognitive function implicated in schizophrenia, in a mouse model of maternal immune activation and adolescent cannabinoid exposure, two important risk factors for schizophrenia.